3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Biphenotypic, Acute
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Drug-Related Side Effects and Adverse Reactions
3
Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Follicular
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hematologic Neoplasms
2
Brain Neoplasms
2
Skin Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Pneumonia
1
Oropharyngeal Neoplasms
1
Metastatic Castration-Resistant Prostate Cancer
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphohistiocytosis, Hemophagocytic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Hepatectomy
1
Down Syndrome
1
Cranial Nerve Diseases
1
Interventions
Cyclophosphamide
47
Rituximab
31
fludarabine
29
Specimen Handling
13
Magnetic Resonance Spectroscopy
13
Doxorubicin
13
pirtobrutinib
11
Vincristine
11
Prednisone
11
fludarabine phosphate
10
Immunotherapy, Adoptive
10
Etoposide
10
Bendamustine Hydrochloride
10
obinutuzumab
8
Lenalidomide
8
Biopsy
8
venetoclax
7
polatuzumab vedotin
7
glofitamab
7
zanubrutinib
6
pembrolizumab
6
Dexamethasone
6
tafasitamab
5
ibrutinib
5
etoposide phosphate
5
acalabrutinib
5
Leukapheresis
5
tazemetostat
4
loncastuximab tesirine
4
Nivolumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Methylprednisolone
×
1 year
×
Clear all
No trials found.